朱崧肇 醫師


醫師代碼:25018我要掛號

專 長

.內科癌症
.血癌
.骨髓移植

現 職

.花蓮慈濟醫院五東病房主任
.花蓮慈濟醫院血液腫瘤科主治醫師
.慈濟大學醫學系專任助理教授

學 歷

.慈濟大學博士班畢業
.慈濟大學醫學系畢業

經 歷

.花蓮慈濟醫院內科部總住院醫師
.花蓮慈濟醫院血液腫瘤科住院總醫師
.佛教慈濟醫療財團法人台北慈濟醫院血液腫瘤科主治醫師

專科醫師證書

.內科專科醫師
.腫瘤內科專科醫師
.血液及骨髓移植專科醫師
.台灣分子醫學專科醫師

獲獎及其他榮譽

.2003年度花蓮慈濟綜合醫院優良員工

論文著作

[1] Chu SC, Wang TF, Su YC, Kao RH, Wu YF, Li DK, et al. Prognostic significance of flow cytometric residual disease, dysregulated neutrophils/monocytes, and hematogones in adult acute myeloid leukemia in first remission. Int J Hematol. 2014;31:31. (SCI)
[2] Huang WH, Li MS, ChuSC, Wang TF, Kao RH, Wu YF. Thalidomide treatment in a myelofibrosis patient with leukemia transformation. Int J Hematol. 2014;99:188-92. (SCI)
[3] Wang TF, Chen SH, Yang SH, Su YC, ChuSC, Li DK. Poor harvest of peripheral blood stem cell in donors with microcytic red blood cells. Transfusion. 2013;53:91-5. (SCI)
[4] van de Loosdrecht AA, Ireland R, Kern W, Della Porta MG, Alhan C, Balleisen JS, et al. Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group. Leuk Lymphoma. 2012;14:14. (SCI)
[5] Wang TF, ChuSC, Chen SH, Huang KP, Su YC, Li DK, et al. The Effect of Different Harvest Strategies on the Nucleated Cell Yields of Bone Marrow Collection. Biol Blood Marrow Transplant. 2011;17:351-5. (SCI)
[6]Chu SC, Wang TF, Li CC, Kao RH, Li DK, Su YC, et al. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes. Leuk Res. 2011;35:868-73. (SCI)
[7] Chen SH, Yang SH, ChuSC, Su YC, Chang CY, Chiu YW, et al. The role of donor characteristics and post-granulocyte colony-stimulating factor white blood cell counts in predicting the adverse events and yields of stem cell mobilization. Int J Hematol. 2011;93:652-9. (SCI)
[8] Li CC, Loken MR, Kao RH, Wang TF, Tsai HH, Hsu SM, et al. Multidimensional Flow Cytometry for the Detection of Rare Populations in Hematological Malignancies. Tzu Chi Med J. 2009;121:40-51.
[9] Kao RH, Li CC, Shaw CK, Wang TF, Chu SC, Chen SH, et al. Correlation between characteristics of unrelated bone marrow donor and cell density of total nucleated cell in bone marrow harvest. Int J Hematol. 2009;89:227-30. (SCI)
[10] 朱 崧肇, 李 啟誠. 神奇藥丸基立克(Glivec ; Imatinib)是否依然神奇?. Biomedicine 生物醫學. 2008;1:96-104.
[11] Wang TF, Wen SH, Chen RL, Lu CJ, Zheng YJ, Yang SH, et al. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings. Biol Blood Marrow Transplant. 2008;14:1305-11. (SCI)
[12] Wang TF, ChuSC, Kao RH, Yao CY, Li CC. A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck. Jpn J Clin Oncol. 2008;38:459-63. (SCI)
[13] Loken MR, ChuSC, Fritschle W, Kalnoski M, Wells DA. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses. Cytometry B Clin Cytom. 2008;76B:27-36. (SCI)
[14] Huang KP, Chase AJ, Cross NC, Reiter A, Li TY, Wang TF, et al. Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia. Int J Hematol. 2008;88:197-201. (SCI)
[15] Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med. 2008;14:1343-50. (SCI)
[16] Li CC, Wang JH, Huang YT, Huang HY, Wang TF, Chu SC, et al. Clinical Experiences with Recombinant Activated Factor VII for Managing Uncontrolled Hemorrhage in Non-Hemophilic Patients. Tzu Chi Med J. 2007;19:220-5.
[17] Wang TF, Liu SH, Kao CH, ChuSC, Kao RH, Li CC. Kimura's disease with generalized lymphadenopathy demonstrated by positron emission tomography scan. Intern Med. 2006;45:775-8. (SCI)
[18] Wang TF, Li CC, ChuSC, Yao CY, Kao RH. Treatment of Metastatic or Recurrent Gastric Cancer with Weekly 24-hour Infusion of Cisplatin and High-Dose 5-Fluorouracil / Leucovorin in an Out-patient Setting. Tzu Chi Med J. 2006;18:432-7.
[19] Wang TF, Horsley SW, Lee KF, ChuSC, Li CC, Kao RH. Translocation between chromosome 5q35 and chromosome 11q13-- an unusual cytogenetic finding in a primary refractory acute myeloid leukemia. Clin Lab Haematol. 2006;28:160-3. (SCI)
[20] Wang TF, ChuSC, Wu MH, Lo R YY, Li CC. Recurrent Syncope as Initial Presenting Symptom of Non-Small Cell Lung Cancer – A Case Report. Tzu Chi Med J. 2006;18:378-81.
[21] Chu SC, Tang JL, Li CC. Dasatinib in chronic myelogenous leukemia. N Engl J Med. 2006;355:1062-3; author reply 3-4. (SCI)
[22] Chu SC, Li CC, Wang TF, Yao CY, Kao RH. Adult Hematopoietic Stem Cell Transplantation in Eastern Taiwan: Initial Results at Tzu Chi Hospital from 2002 to 2005. Tzu Chi Med J 2006;18:97-100.
[23] Chang ET,Ju SC, Lee KF, Kao RH. Central diabetes insipidus and monosomy 7 in myeloid crisis of chronic myeloid leukemia. Leuk Lymphoma. 2006;47:1407-8. (SCI)

學會報告:
1. Chu SC et al, Adult Hematopoietic Stem Cell Transplantation in Eastern Taiwan.    130th Taiwan Hematology Society, Hualien, Taiwan, July 23, 2005
2.Chu SC et al, Cisplatin and Vinorelbine in Patients with Metastatic Breast Cancer after Failure of Taxane - and/or Anthracycline -containing Regimens The 11th Taiwan Joint Cancer Conference,Taipei, Taiwan, May 2006
3. Chu SC et al, Flow cytometric scoring system as a potential diagnostic and prognostic tool in myelodysplastic syndrome,中華民國血液及骨髓移植學會暨中華民國血液病學會九十九年度聯合年會,會員演講, April 2010
4. Chu SC et al, Flow cytometric scoring system as a potential diagnostic and prognostic tool in myelodysplastic syndrome, 52th ASH Annual Meeting and Exposition, Poster, Dec 2010
5. Chu SC et al, Prognostic Significance of Flow Cytometric Minimal Residual Disease, Return to MDS and Hematogones in Adult Acute Myeloid Leukemia in First Remission, 2011 53th ASH Annual Meeting and Exposition, Poster, Dec 2011
6. Chu SC et al, Prognostic Significance of Flow Cytometric Minimal Residual Disease, Return to MDS and Hematogones in Adult Acute Myeloid Leukemia in First Remission,中華民國血液及骨髓移植學會暨中華民國血液病學會101年度聯合年會,會員演講, April 2012

國科會計畫

漿液性輸卵管上皮癌細胞之腹膜癌化和腹膜趨化性機制研究(102-2314-B-303-015-MY3) 2013/08/01~
2016/07/31
主持人
以輸卵管上皮癌化模式研究卵巢漿液性癌的細胞來源與癌化過程(101-2314-B-303-020-) 2012/08/01~
2013/07/31
主持人

 

 

團隊陣容

Copyright © 2020 花蓮慈濟醫院. 版權所有. 地址:花蓮市中央路三段707號 連絡電話:03-8561825